Can Levothyroxine Cause High Cholesterol?

Levothyroxine does not cause high cholesterol. It does the opposite: by replacing the thyroid hormone your body is not making enough of, levothyroxine typically brings cholesterol levels down. The confusion usually starts when someone on levothyroxine still has elevated cholesterol on their lab work, which can happen for several reasons that have nothing to do with the drug itself pushing numbers up. Understanding why hypothyroidism raises cholesterol in the first place makes the whole picture clearer.

Why Low Thyroid Hormone Raises Cholesterol

Your liver is the central processing plant for cholesterol. It pulls LDL cholesterol out of your bloodstream using LDL receptors on its surface. Thyroid hormone controls how many of those receptors your liver produces. When thyroid hormone levels drop, the liver makes fewer LDL receptors, and cholesterol accumulates in the blood because the liver is not grabbing it as efficiently.¹ Research has shown that this effect is driven by a protein called SREBP-2, which acts as a master switch for both LDL receptor production and cholesterol processing in liver cells. When thyroid hormone is low, SREBP-2 activity drops, and the liver’s ability to clear LDL from the blood drops with it.²

The result is a recognizable pattern on blood work. People with an underactive thyroid tend to have higher total cholesterol, higher LDL (“bad” cholesterol), and sometimes higher triglycerides.³ HDL (“good” cholesterol) tends to stay roughly the same or move less dramatically. This is one reason lipid guidelines recommend checking thyroid function in people who show up with unexplained high cholesterol.⁴

What Levothyroxine Actually Does to Cholesterol

Because hypothyroidism is the cause of the cholesterol problem, treating it with levothyroxine reverses the effect. A systematic review of studies on hypothyroid patients found that levothyroxine therapy leads to significant decreases in total cholesterol, LDL, and triglycerides.⁵ One study of hypothyroid patients found that after treatment, average total cholesterol fell from roughly 204 to 167 mg/dL, and average LDL fell from about 124 to 96 mg/dL.⁶ Those are meaningful drops. HDL, interestingly, did not change much in the same study, which fits with the idea that the thyroid’s main effect on cholesterol runs through the LDL clearance pathway.

Earlier research in patients with subclinical hypothyroidism, the milder form where TSH is elevated but thyroid hormone levels are still in the normal range, showed a similar pattern. In one trial, LDL cholesterol dropped from about 143 mg/dL before treatment to 112 mg/dL after two months of levothyroxine, a decline that held steady at four months.⁷ The evidence is consistent: levothyroxine is a cholesterol-lowering treatment in people whose cholesterol is high because of an underactive thyroid.

Why Cholesterol Can Stay High on Levothyroxine

If the drug lowers cholesterol, why do some people on levothyroxine still see high numbers? The most common reason is that their thyroid replacement is not yet adequate. Levothyroxine dosing takes time to get right. Your doctor starts at a dose based on your weight and age, then adjusts over several weeks or months based on blood work. Until your TSH and free thyroid hormone levels are in the target range, your cholesterol may not fully respond. A placebo-controlled trial in subclinical hypothyroidism found that the LDL-lowering effect was most pronounced in patients whose baseline TSH was highest and whose LDL was most elevated to begin with, meaning the sicker your thyroid, the bigger the cholesterol payoff from proper dosing.⁸ But the flip side is also true: if your dose is too low and your TSH is still creeping up, your cholesterol may not budge much.

A second common culprit is poor absorption. Levothyroxine is a finicky drug when it comes to the gut. Plenty of everyday substances interfere with how much of the pill actually gets into your bloodstream. One study found that when patients’ levothyroxine absorption was impaired by calcium carbonate supplements, their TSH crept up, and for every 1.0 mU/L increase in TSH (within the 0.85 to 6.9 range), total cholesterol rose by about 12 mg/dL.⁹ That is a surprisingly steep relationship: small shifts in how well your body absorbs the drug can translate into meaningful changes on a lipid panel.

Common Absorption Saboteurs

The list of things that can reduce levothyroxine absorption is longer than most people expect. A review of the evidence identified several categories.¹⁰

Food and beverages: Eating too soon after taking your pill, high-fiber diets, and espresso coffee can all reduce absorption. The standard advice to take levothyroxine on an empty stomach 30 to 60 minutes before eating exists for this reason.
Supplements and antacids: Calcium carbonate, iron (ferrous sulfate), and aluminum-containing antacids are among the most common offenders. These bind to levothyroxine in the gut and prevent it from being absorbed.
Stomach-acid drugs: Proton-pump inhibitors, the class of drugs that includes omeprazole and similar medications, can reduce absorption by changing stomach acidity.
Gut conditions: Celiac disease, inflammatory bowel disease, lactose intolerance, and Helicobacter pylori infection all affect how the intestine absorbs levothyroxine.
Cholesterol-lowering resins: This one is ironic: cholestyramine, a drug sometimes prescribed to lower cholesterol, binds thyroid hormone in the gut and interferes with its absorption. Patients taking both drugs need to separate them by at least four hours.¹¹

Any of these factors can quietly undermine your levothyroxine, leaving your thyroid under-treated and your cholesterol stubbornly elevated. If your lipid numbers are not improving despite being on thyroid medication, absorption issues are one of the first things worth investigating with your doctor.

Subclinical Hypothyroidism and the Smaller Effect

Subclinical hypothyroidism occupies a gray zone. Your TSH is above normal, but your actual thyroid hormone levels are still technically in range, and you may have few or no symptoms. The cholesterol effects in this group are real but smaller than in full-blown hypothyroidism. A randomized, placebo-controlled trial found that levothyroxine treatment in subclinical hypothyroidism reduced total cholesterol by about 3.8% and LDL by about 8.2%, with no change in the placebo group.⁸

Another placebo-controlled study confirmed that only LDL levels were specifically and reversibly elevated in subclinical hypothyroidism, and that levothyroxine brought them down in proportion to how high the baseline levels were.¹² The takeaway is that treating subclinical hypothyroidism does help cholesterol, but the improvement is moderate. If you had high cholesterol before your thyroid started underperforming, levothyroxine alone may not be enough to normalize your numbers.

When the Problem Is Not Your Thyroid at All

High cholesterol has many causes, and an underactive thyroid is only one of them. Diet, genetics, body weight, physical activity, age, and other medical conditions all contribute independently. Once levothyroxine brings your thyroid hormones into the normal range, any remaining cholesterol elevation is likely due to those other factors. Some people expect levothyroxine to be a complete fix, and it can be disappointing when lipid panels improve but do not normalize.

This is worth emphasizing because it shapes clinical decisions. If your TSH is in range and your cholesterol is still high, your doctor is unlikely to increase your levothyroxine dose to chase a better lipid number. Over-replacement with thyroid hormone carries its own risks, including bone loss and heart rhythm problems. Instead, the remaining cholesterol issue gets addressed with lifestyle changes or separate lipid-lowering medication.

How Menopause Complicates the Picture

Menopause changes cholesterol independently of the thyroid. Estrogen has protective effects on the lipid profile, and when estrogen levels decline at menopause, total cholesterol and LDL tend to rise. This means that a woman being treated with levothyroxine who enters menopause may see her cholesterol go up even though her thyroid is well controlled. A large cross-sectional study found that the link between thyroid dysfunction and abnormal lipids was strongest in premenopausal women and weakened after menopause, partly because postmenopausal women already had higher cholesterol regardless of thyroid status.¹³

Another population study found that in premenopausal women, TSH levels tracked directly with total cholesterol, LDL, and triglycerides, but after menopause the relationship narrowed to triglycerides alone.¹⁴ For postmenopausal women on levothyroxine, this means that even perfectly dosed thyroid replacement will have a smaller effect on LDL than it would have had before menopause. The cholesterol that remains is being driven by the loss of estrogen and other age-related metabolic changes, not by inadequate thyroid treatment.

The Levothyroxine-Only Versus Combination Therapy Debate

Some patients who still feel unwell or have persistent lipid problems on levothyroxine wonder whether adding T3 (liothyronine) might help. Levothyroxine provides T4, which the body converts into the more active T3 hormone. The theory is that some people do not convert T4 efficiently and could benefit from getting T3 directly. One small trial found that combination T4/T3 therapy lowered cholesterol and LDL more than T4 alone.¹⁵ A more recent meta-analysis also found a significant improvement in LDL cholesterol with combination therapy.¹⁶

However, the broader evidence is less enthusiastic. Multiple randomized trials and meta-analyses have found that combining T4 and T3 is generally no better than T4 alone for most outcomes, and any lipid benefit tends to appear only when the combination pushes TSH into a suppressed range, which introduces risks to the heart and bones.¹⁷ T3 monotherapy can lower cholesterol and body fat, but its short half-life and high biological activity make it difficult to manage safely. For most people, optimizing levothyroxine dosing and addressing other causes of high cholesterol remains the standard approach.

Thyroid-Targeted Cholesterol Drugs

The powerful connection between thyroid hormone and cholesterol has attracted interest from a different angle. Researchers have spent years trying to develop drugs that mimic thyroid hormone’s cholesterol-lowering effect on the liver without triggering the harmful effects thyroid hormone has on the heart, bones, and muscles.¹⁸ The liver primarily uses one type of thyroid hormone receptor (called TRβ), while the heart uses a different one (TRα). By designing molecules that activate only the liver receptor, it becomes possible to lower cholesterol through the same mechanism the thyroid uses naturally.

One such compound, resmetirom (originally called MGL-3196), reduced non-HDL cholesterol and liver triglycerides in trials without affecting TSH levels or causing changes to heart size or bone density.¹⁹ Resmetirom eventually received FDA approval in 2024 for a liver condition called nonalcoholic steatohepatitis (NASH), making it the first approved drug in this class. Animal research has also shown that thyroid hormones can lower cholesterol through a second pathway entirely separate from LDL receptors, one that reduces the liver’s production of the protein that carries LDL particles in the blood.²⁰ This secondary route may explain why thyroid-based approaches to cholesterol lowering could eventually complement or offer alternatives to statins for certain patients.

Screening for Thyroid Problems When Cholesterol Is High

Because the relationship between thyroid function and cholesterol is so direct, checking thyroid levels should be part of any initial workup for unexplained high cholesterol. A study of a large cohort of patients referred specifically for lipid problems recommended that all such patients be screened for hypothyroidism by measuring TSH.⁴ This is practical advice that sometimes gets overlooked. If a person starts a statin for high cholesterol but the underlying cause is an undiagnosed underactive thyroid, they may end up on medication they did not need. Fixing the thyroid problem first can sometimes resolve the cholesterol issue on its own, or at least reduce the dose of lipid-lowering medication required.

For people already on levothyroxine, the same logic applies in reverse. If your cholesterol is not responding to treatment as expected, your doctor should confirm that your thyroid levels are actually in range, check for absorption problems, and review any medications or supplements you take that might interfere. Cholesterol that remains high after all of that is likely independent of your thyroid and deserves its own targeted treatment plan.

1
PubMed. Thyroid disease and lipids
2
Journal of Biological Chemistry. Thyroid Hormone Regulation and Cholesterol Metabolism Are Connected through Sterol Regulatory Element-binding Protein-2 (SREBP-2)
3
PubMed Central. Effects of thyroid dysfunction on lipid profile
4
JAMA Internal Medicine. Prevalence and Correction of Hypothyroidism in a Large Cohort of Patients Referred for Dyslipidemia
5
PubMed Central. Effect of Levothyroxine Therapy on the Lipid Profile of Patients With Hypothyroidism: A Systematic Review
6
PubMed Central. Investigating the effect of levothyroxine replacement on cholesterol levels in hypothyroid patients
7
JAMA Internal Medicine. Lipoprotein and Apolipoprotein Levels in Subclinical Hypothyroidism: Effect of Levothyroxine Therapy
8
The Journal of Clinical Endocrinology & Metabolism. TSH-Controlled l-Thyroxine Therapy Reduces Cholesterol Levels and Clinical Symptoms in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Trial (Basel Thyroid Study)
9
PubMed. L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia
10
PubMed. Conditions and drugs interfering with thyroxine absorption
11
JAMA. The Influence of Cholestyramine on Thyroxine Absorption
12
PubMed. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study
13
PubMed Central. Menopausal Impact on the Association Between Thyroid Dysfunction and Lipid Profiles: A Cross-Sectional Study
14
PubMed Central. Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study
15
Hormones. Combined therapy with L-Thyroxine and L-Triiodothyronine compared to L-Thyroxine alone in the treatment of primary hypothyroidism
16
Bali Medical and Wellness Journal. Efficacy of Levothyroxine (LT4) and Liothyronine (T3) Combination Therapy vs. LT4 Monotherapy for Hypothyroidism: A Meta-Analysis
17
The Journal of Clinical Endocrinology & Metabolism. Persistent Dyslipidemia in Patients With Hypothyroidism: A Good Marker for Personalized Replacement Therapy?
18
Frontiers in Medicine. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
19
PubMed Central. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia
20
PubMed Central. Thyroid hormone reduces cholesterol via a non-LDL receptor-mediated pathway